1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Zelira Therapeutics Limited
  6. Summary
    ZLD   AU000000ZLD1

ZELIRA THERAPEUTICS LIMITED

(ZLD)
  Report
Delayed Australian Stock Exchange  -  05/23 11:19:30 pm EDT
1.400 AUD   +3.70%
05/16Zelira Therapeutics' Hope 1 Drug Shows Therapeutic Effects in Autism Spectrum Disorder Patients
MT
05/12Zelira Therapeutics Ltd Announces Resignation of Harry Karelis as Non-Executive Vice Chairman
CI
05/11TRANSCRIPT : Zelira Therapeutics Limited - Special Call
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Australian Stock Exchange
05/17/2022 05/18/2022 05/19/2022 05/20/2022 05/23/2022 Date
1.38(c) 1.275(c) 1.38(c) 1.63(c) 1.35(c) Last
21 309 12 618 4 993 25 315 16 440 Volume
+17.45% -7.61% +8.24% +18.12% -17.18% Change
More quotes
Estimated financial data (e)
Sales 2022 2,89 M 2,05 M 2,05 M
Net income 2022 - - -
Net Debt 2022 - - -
P/E ratio 2022 -
Yield 2022 -
Sales 2023 5,77 M 4,10 M 4,10 M
Net income 2023 - - -
Net Debt 2023 - - -
P/E ratio 2023 -
Yield 2023 -
Capitalization 15,6 M 11,1 M 11,1 M
Capi. / Sales 2022 5,41x
Capi. / Sales 2023 2,70x
Nbr of Employees -
Free-Float 87,4%
More Financials
Company
Zelira Therapeutics Limited is an Australia-based cannabinoid-based biopharmaceutical company. It is focused on developing and clinically validating branded cannabinoid-based medicines for the treatment of a variety of medical conditions in its prescription (Rx) business, including insomnia, autism and chronic non-cancer pain. Its lead product, Zenivol, is a cannabinoid-based medicine for the treatment of chronic... 
More about the company
All news about ZELIRA THERAPEUTICS LIMITED
05/16Zelira Therapeutics' Hope 1 Drug Shows Therapeutic Effects in Autism Spectrum Disorder ..
MT
05/12Zelira Therapeutics Ltd Announces Resignation of Harry Karelis as Non-Executive Vice Ch..
CI
05/11TRANSCRIPT : Zelira Therapeutics Limited - Special Call
CI
05/08Zelira Therapeutics Launches New Relief Cream Product
MT
05/08Zelira Therapeutics Limited Successfully Launches ITURA with CVSCM
CI
04/28Zelira Therapeutics Logs $340,000 Cash Receipts in Fiscal Q3; Shares Fall 3%
MT
04/21ZELIRA THERAPEUTICS : Update - Consolidation/Split - ZLD
PU
04/18ZELIRA THERAPEUTICS : and Health House execute Scheme Implementation Deed
PU
04/14ZELIRA THERAPEUTICS LIMITED : REVERSE SPLIT: 1 of 175
FA
04/12ZELIRA THERAPEUTICS : Update - Consolidation/Split - ZLD
PU
04/11TRANSCRIPT : Zelira Therapeutics Limited - Shareholder/Analyst Call
CI
04/05Zelira Therapeutics Limited Announces Update on EDCDM Technology Licence Agreement
CI
03/13ZELIRA THERAPEUTICS : Consolidation/Split - ZLD
PU
02/28ZELIRA THERAPEUTICS : Appendix 4D & FY22 Interim Financial Report
PU
02/28ZELIRA THERAPEUTICS : Application for quotation of securities - ZLD
PU
More news
News in other languages on ZELIRA THERAPEUTICS LIMITED
05/12Zelira Therapeutics Ltd annonce la démission de Harry Karelis en tant que vice-présiden..
05/08Zelira Therapeutics Limited lance avec succès ITURA avec CVSCM
04/28Zelira Therapeutics enregistre des rentrées de fonds de 340 000 $ au troisième trimestr..
04/05Zelira Therapeutics Limited annonce une mise à jour sur l'accord de licence de la techn..
02/23Zelira Therapeutics Limited annonce ses résultats pour le semestre clos le 31 décembre ..
More news
Chart ZELIRA THERAPEUTICS LIMITED
Duration : Period :
Zelira Therapeutics Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ZELIRA THERAPEUTICS LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 0
Last Close Price 1,35 AUD
Average target price 11,70 AUD
Spread / Average Target 767%
Managers and Directors
Oludare Odumosu Chief Executive Officer, Director & MD
Osagie O. Imasogie Chairman
Timothy Ryan Slate Secretary & Non-Executive Director
Lisa Gray Director
Jason William Peterson Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
ZELIRA THERAPEUTICS LIMITED-71.77%11
GILEAD SCIENCES, INC.-12.33%80 075
REGENERON PHARMACEUTICALS, INC.7.98%71 235
VERTEX PHARMACEUTICALS22.20%66 136
WUXI APPTEC CO., LTD.-17.77%42 735
BIONTECH SE-36.77%39 612